Click here to see a list of our past events.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional. The May 22nd office hours will be hosted by Jamie Brisbois, Ph.D., Manager, Business Development and Licensing.
Jamie collaborates with Weill Cornell Medicine innovators to identify, market and license life sciences technologies. Prior to joining the Center for Technology Licensing in 2021, Jamie worked as a consultant with ClearView Healthcare Partners, a boutique health care consulting firm based in Boston. In addition, he served three years as a fellow with Columbia Technology Ventures (CTV), the technology transfer office of Columbia University.
Register here for your 30-minute private session.
Join us for a virtual presentation exploring the practical implications of incorporating artificial intelligence (AI) tools in academic research and innovation. As AI becomes increasingly integrated into research methodologies, understanding how to properly document and manage AI assistance in the invention process is crucial for protecting intellectual property rights.
This interactive session will address key concerns facing researchers, including:
- Strategic approaches to incorporating AI tools in your research workflow
- Best practices for documenting AI assistance during invention conception and development
- Practical guidelines for maintaining transparent records of AI interactions (prompts and outputs)
- Protecting IP potential while leveraging AI capabilities
- Understanding the concept of hybrid inventorship in the AI era
Hosted by Martin Teschl, Director of BD & Licensing, our guest speaker David Sanker, Founder of Sanker IP, will provide actionable insights and practical frameworks for researchers looking to optimize their use of AI while safeguarding their intellectual property interests.
An infusion of non-dilutive funding like SBIR/STTR grants can propel a startup forward — but what comes after you win? Entrepreneurs are invited to join Rev: Ithaca Startup Works and Renata Dabrowska, CPA at Sciarabba Walker & Co., LLP, for a virtual content session focused on the crucial accounting steps after receiving an SBIR or STTR award.
In this informative session, Dabrowska will demystify post-award requirements and share best practices for compliant and strategic financial management. From setting up proper accounting systems to managing federal reporting and audits, attendees will walk away with actionable insights to help their ventures stay on track.
Admission is free and open to all. RSVP today.
Biotech XYZ, BioVenture eLab (a part of Enterprise Innovation), Chai Ventures, IndieBio, and SOSV are teaming up to host a collaborative event focused on the future of women’s health.
The Latest Innovations in Women’s Health will bring together leaders across biotech, venture, and research to explore cutting-edge advancements in the space. Instead of a traditional panel, we’re hosting an interactive format with breakout-style discussion pods led by experts and operators.
These are the six topics we’ll be diving into:
- Personalized Medicine for Hormone Health
- Bridging Gaps in Healthtech Funding
- Digital Therapeutics, Innovation & Clinical Trials in Women’s Health
- Lab to Market: Scaling Startups
- Aging, Longevity & Holistic Health
- Chronic Conditions That Disproportionately Impact Women
This is an invite-only gathering for founders, funders, researchers and operators passionate about advancing women’s health outcomes.
We hope you’ll join us for a thoughtful and energizing evening. RSVP by May 2nd to secure your spot! Your registration is subject to approval by the host.
Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), the virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor Ken Rother will be joined by Hunter Adams, a new instructor and program alum, to share their experience and answer questions.
The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products and processes with the potential to benefit society.
Register here.
Ready to secure non-dilutive funding to take your startup to the next level?
Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. During the workshop, Macolini will discuss and answer questions regarding writing and submitting a successful SBIR/STTR proposal and identifying strategies for making your SBIR/STTR proposal more competitive.
Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
- An overview of the SBIR/STTR programs
- Program eligibility requirements
- Differences between SBIR and STTR agencies
- Using SBIR/STTR to enhance your company's value
The event is free and open to the public. Register to reserve your spot.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional.
The April 17th office hours will be hosted by Louise Sarup, Ph.D., Associate Director, Business Development and Licensing. Louise manages a portfolio of medical technologies focusing on imaging, platform technologies and algorithms. She is a seasoned professional with years of experience in licensing and commercialization and is eager to answer your questions and provide valuable insights.
Prior to joining the Center for Technology Licensing, Louise was based in Singapore where she was head of business development and licensing for D3 (now EDDC), a drug discovery and development group based at A*STAR. Some of her previous roles include corporate development manager at S*BIO Pte Ltd. (Singapore), an oncology-focused biotech, vice president of business development at Paramount Biosciences (London), where she was responsible for in-licensing drug development assets and director (licensing) at Cytiva, a global life science company. Louise has also worked for leading life science and health care communication agencies and UCL Business, the commercialization company of University College London.
Register here for your 30-minute private session.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to get an answer to their intellectual property questions and gain more information about the advancement of their IP filings with a one-on-one meeting.
The Tuesday, April 15, office hours will be hosted virtually by Eric Bryant, M.S., J.D., Intellectual Property Officer, Biomedical Sciences.
Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution. Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
To reserve your private, 30-minute Zoom session with Eric, click here and select your preferred time.
Join our distinguished special panel to explore the critical intersection of medical device innovation and regulatory guidance. The panel will unpack the complex path from scientific discovery to market-ready medical innovation. We'll explore the strategic, technical and regulatory considerations that transform promising research into technologies that can improve patient care.
This session is ideal for anyone interested in medical devices and understanding the journey from idea to real-world healthcare applications.
Our expert panelists will share their practical insights on:
- Navigating FDA approval processes
- Balancing innovation with regulatory compliance
- Strategies for successful device development
- Emerging challenges in medical device development
Whether you're considering a new idea, commercialization, or actively developing medical device solutions, this panel offers valuable perspectives on turning promising research into market-ready medical devices.
Panelists:
- Mark Melkerson, former FDA Deputy Director, Office of Health Technology / CDRH / ODE and current MNM Consulting
- Thomas Roueche, President and CEO, Fesarius Therapeutics
- Jason Spector, M.D., Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, Co-Founder of Fesarius Therapeutics
As a graduate student, many career options lie in front of you. One potential route is founding a startup based on the innovative research conducted in your lab. Beginning a startup company is complex and challenging. While there are now many programs to assist academics in their startup endeavors, some aspects you learn as you build the venture. Come hear from two successful startup CEOs who founded startups as graduate students. They will discuss their journeys:
- Making the switch from academia to a new venture
- Fundraising
- Building their teams
- Challenges both expected and unforeseen
- The ultimate exits made by their first startups
Dr. Shelley Force Aldred founded her first startup as a graduate student at Stanford University and now is on her third new venture. Dr. Laura Schewel founded her first startup, StreetLight Data, while a graduate student at Berkeley.
Learn more about both speakers and register here.
